-
Mashup Score: 1Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis - 6 month(s) ago
Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS) are defined by somatic mutations in genes associated with myeloid neoplasms (MN) at a…
Source: evidence.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21
The guidelines for classification, prognostication, and response assessment of myelodysplastic syndromes/neoplasms (MDS) have all recently been update…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Blood Cancer Quality of Life Grant - 6 month(s) ago
LLSC is the largest voluntary health organization dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients.
Source: www.bloodcancers.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
The guidelines for classification, prognostication, and response assessment of myelodysplastic syndromes/neoplasms (MDS) have all recently been update…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0👯 Who is your Twitter twin? - 1 year(s) ago
Discover your twin on Twitter now!
Source: ToasteedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1DDX41-associated susceptibility to myeloid neoplasms - 1 year(s) ago
Routine use of next-generation sequencing of hematologic malignancies has greatly expanded the representation of hereditary predisposition syndromes among patie
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0We Asked GPT-3 to Write an Academic Paper about Itself—Then We Tried to Get It Published - 1 year(s) ago
An artificially intelligent first author presents many ethical questions—and could upend the publishing process
Source: Scientific AmericanCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Patient’s white blood cells genetically changed into cancer killers - Hamilton Health Sciences - 1 year(s) ago
A new medication available at Hamilton Health Sciences for CAR T-cell therapy brings hope to some end-of-life patients.
Source: Hamilton Health SciencesCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Reflections on a rich and remarkable life - Macleans.ca - 2 year(s) ago
In 2019, an MDS diagnosis stopped Bob Markovich in his tracks. With his condition now under control, he’s able to look back on a life well-lived while remaining focused on the future
Source: Macleans.caCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Macleans.ca - Canada's magazine since 1905 - 2 year(s) ago
Canada’s magazine since 1905
Source: Macleans.caCategories: Hem/Oncs, Latest HeadlinesTweet
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis | NEJM Evidence. CHRS provides a simple prognostic framework for CHIP/CCUS, distinguishing a high-risk minority from the majority of CHIP/CCUS, which has a minimal risk of progression to MN https://t.co/QIAEORU11V